Universal Biosensors surges 60% on FDA approval for Class II device
Universal Biosensors shares surged 60% following the attainment of US Food and Drug Administration and Clinical Laboratory Improvement Amendments Waiver approvals.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
WRR | Ann: Change of Company Name & New ASX Code | 22/11/18 | 0 | 1.9K | |||
|
|||||||
WRR | Ann: Major Shipments of Thuraya WE Terminals Continue | 16/11/18 | 0 | 1.2K | |||
|
|||||||
WRR | Ann: Appendix 4C September Quarter 2018 | 31/10/18 | 0 | 951 | |||
|
|||||||
WRR | Ann: AGM 2018 - Voting Results of Meeting | 26/10/18 | 0 | 1.4K | |||
|
|||||||
WRR | Ann: Investor Update - MD Presentation to AGM 2018 | 26/10/18 | 0 | 1.3K | |||
|
|||||||
WRR | Ann: Notice of 2018 AGM, Proxy Form and Annual Report | 26/09/18 | 0 | 639 | |||
|
|||||||
WRR | Ann: Deliveries of Thuraya WE Devices to Commence | 26/09/18 | 1 | 1.6K | |||
|
|||||||
WRR | Ann: Appendix 4G for the Year Ending 30 June 2018 | 12/09/18 | 0 | 1.8K | |||
|
See All Discussions